Who
Stephanie Lovell
Director
Company insider
Files Form 4 as: Director, TransMedics Group; Director, Cyclerion Therapeutics.
In numbers
- Trades disclosed
- 26
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $978K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 1 Apr 2019
- Last trade
- 20 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 May 2026filed 22 May 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —2,922 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —2,922 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Sold | $178K1,193 at $149.62 | filing |
| 4 Mar 2026filed 6 Mar 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Sold | $178K1,193 at $149.62 | filing |
| 22 May 2025filed 23 May 2025 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —2,134 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,154 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —732 at $0.00 | filing |
| 25 May 2023filed 30 May 2023 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,916 at $0.00 | filing |
| 25 May 2023filed 30 May 2023 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —1,193 at $0.00 | filing |
| 23 Nov 2022filed 23 Nov 2022 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code M | —5,657 at $0.00 | filing |
| 23 Nov 2022filed 23 Nov 2022 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code M | $271K5,657 at $47.82 | filing |
| 23 Nov 2022filed 23 Nov 2022 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Sold | $337K5,657 at $59.50 | filing |
| 22 Nov 2022filed 23 Nov 2022 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,800 at $0.00 | filing |
| 22 Nov 2022filed 23 Nov 2022 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,100 at $0.00 | filing |
| 22 Nov 2022filed 23 Nov 2022 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code M | $182K3,800 at $47.82 | filing |
| 22 Nov 2022filed 23 Nov 2022 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Sold | $220K3,800 at $57.97 | filing |
| 22 Nov 2022filed 23 Nov 2022 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code M | $29K1,100 at $26.26 | filing |
| 22 Nov 2022filed 23 Nov 2022 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Sold | $64K1,100 at $58.04 | filing |
| 14 Jun 2022filed 16 Jun 2022 | Cyclerion Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 1 Jun 2022filed 6 Jun 2022 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code A | —13,500 at $0.00 | filing |
News
TransMedics Group (NASDAQ:TMDX) and Cerus (NASDAQ:CERS) Head-To-Head ContrastTMDX · themarketsdaily.com · 13 Oct 2026TransMedics Group (NASDAQ:TMDX) Research Coverage Started at BarclaysTMDX · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Stephanie Lovell; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.